^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

nanrilkefusp alfa (SOT101)

i
Associations
Trials
Company:
Sotio
Drug class:
IL-2 stimulant, IL-15 superagonist
Related drugs:
Associations
Trials